Analyst Expectations for Steris's Future
Portfolio Pulse from Benzinga Insights
Analysts have provided ratings for Steris (NYSE:STE) with 2 somewhat bullish and 3 indifferent ratings in the last quarter. The average 12-month price target for Steris is $232.00, with a high of $265.00 and a low of $215.00, marking a 4.66% increase from the previous target of $221.67. Analyst ratings are updated quarterly and are based on financial analysis and insider information.
December 04, 2023 | 3:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Steris has received 2 somewhat bullish and 3 indifferent ratings from analysts, with an updated average 12-month price target of $232.00, reflecting a 4.66% increase from the previous target.
The increase in the average price target for Steris suggests a positive outlook from analysts, which could lead to increased investor confidence and a potential short-term rise in the stock price. The ratings indicate a neutral to somewhat bullish sentiment, which is likely to be taken positively by the market. However, as the ratings are not strongly bullish, the impact may be moderate rather than significant.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100